Penalty Amount
$29,600,000
Oregon Attorney General Dan Rayfield and a bipartisan coalition of states reached a $29.6 million settlement with Glenmark, a generic drug manufacturer accused of conspiring with other pharmaceutical companies to inflate prices and limit competition for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate litigations and implement internal reforms to ensure fair competition and antitrust compliance.
Glenmark will pay $29.6 million, cooperate in ongoing multistate litigations against 33 corporate defendants and 25 individual executives, and implement internal reforms to ensure fair competition and compliance with antitrust laws.
In-house legal teams should review vendor agreements with pharmaceutical manufacturers and suppliers for any clauses related to pricing, market allocation, or information sharing that could raise antitrust concerns. Specifically, contracts should be examined for provisions that might facilitate collusion, such as agreements to share competitively sensitive pricing data, restrict output, or allocate markets. Additionally, any cooperation or settlement agreements with government entities should be reviewed to ensure compliance with ongoing litigation requirements and internal reform mandates.
Entity
Glenmark Pharmaceuticals
Industry
PharmaceuticalOfficial Press Release
https://www.doj.state.or.us/media-home/news-media-releases/ag-rayfield-takes-on-inflated-drug-prices-with-29-6m-settlement/
Glenmark
https://www.doj.state.or.us/wp-content/uploads/2026/07/Glenmark.pdf
Oregon Attorney General Enforcement Page
https://www.doj.state.or.us/consumer-protection/
"Glenmark"
"$29.6 million settlement"
"antitrust laws"
"inflating prices and limiting competition"
"bipartisan coalition of other states"
$29.6M
Minnesota Attorney General Keith Ellison joined a 48-state coalition in a $29.6 million settlement with generic-drug manufacturer Glenmark to resolve allegations of a widespread conspiracy to artificially inflate and manipulate prices, reduce competition, and restrain trade for numerous generic prescription drugs. The settlement requires Glenmark to cooperate in ongoing multistate lawsuits and implement internal reforms to ensure compliance with antitrust laws.
$29.6M
Attorney General Phil Weiser joined a bipartisan coalition of 48 states and territories in announcing a $29.6 million settlement with Glenmark Pharmaceuticals. The settlement resolves allegations that Glenmark participated in a widespread conspiracy to inflate prices, reduce competition, and restrain trade for numerous generic prescription drugs. Glenmark also agreed to cooperate in ongoing multistate litigation and implement internal reforms.
Oregon Attorney General Dan Rayfield joined a multistate coalition in filing a lawsuit challenging NHTSA’s rollback of fuel economy standards. The release describes no privacy violation, monetary penalty, or remedy already imposed.
An Oregon judge rejected RealPage’s attempt to have the state’s rent-pricing lawsuit dismissed, allowing the case to move forward. Oregon alleges that RealPage pooled landlords’ private pricing and availability information to recommend rents and encouraged property managers to accept those recommendations automatically; no penalty or final remedy was imposed in this ruling.
$400.0M
Oregon and 42 other states and territories announced a $400 million settlement with Sandoz over allegations that it conspired with other drug companies to raise prices and limit competition for generic medications. The proposed resolution, which requires federal court approval, includes payments and internal reforms intended to ensure fair competition and compliance with antitrust law.
Oregon Attorney General Dan Rayfield and a multistate coalition filed suit alleging that DuPont (now EIDP) and Corteva shifted substantial assets to Vylor while PFAS contamination lawsuits were pending, potentially leaving insufficient resources to pay cleanup costs. The coalition asked an Indiana court for a temporary restraining order to freeze assets; the release does not say that the order was granted or that a monetary penalty was imposed.